Mirae Asset Healthcare Fund
Mirae Asset Mutual Fund · FM: Vrijesh Kasera, Tanmay Mehta · INF769K01ED6 · Direct
NAV ₹51.71 AUM ₹3253 Cr as of 07 Aug 2026
Latest available portfolio · Retrieved: 8-Aug-2026 11:26 PM IST · Disclosure date not provided
Returns
| 1D | 1M | 3M | 6M | 1Y | 3Y | 5Y | Rank (1Y) | TER | |
|---|---|---|---|---|---|---|---|---|---|
| Fund | +0.2% | +4.6% | +9.7% | +25.2% | +21.7% | +23.0% | +16.0% | 1/13 | — |
Equity allocation
99.78%
Debt allocation
0.00%
Cash / Liquid
0.22%
Other
0.01%
All Equity Holdings (28) latest available
| # | Company | Value (₹ Cr) | % of AUM |
|---|---|---|---|
| 1 | Sun Pharmaceuticals Industries Ltd | 356.1 | 10.95% |
| 2 | Divi's Laboratories Ltd | 244.9 | 7.53% |
| 3 | J.B. Chemicals & Pharmaceuticals Ltd | 211.1 | 6.49% |
| 4 | Apollo Hospitals Enterprise Ltd | 198.2 | 6.09% |
| 5 | Glenmark Pharmaceuticals Ltd | 198.0 | 6.09% |
| 6 | Laurus Labs Ltd | 149.9 | 4.61% |
| 7 | Dr Reddy's Laboratories Ltd | 140.9 | 4.33% |
| 8 | Aurobindo Pharma Ltd | 140.9 | 4.33% |
| 9 | Lupin Ltd | 134.3 | 4.13% |
| 10 | Krishna Institute of Medical Sciences Ltd | 125.2 | 3.85% |
| 11 | Fortis Healthcare Ltd | 123.7 | 3.80% |
| 12 | Alkem Laboratories Ltd | 115.2 | 3.54% |
| 13 | OneSource Specialty Pharma Ltd | 108.9 | 3.35% |
| 14 | Sai Life Sciences Ltd | 106.1 | 3.26% |
| 15 | Ipca Laboratories Ltd | 105.0 | 3.23% |
| 16 | Cipla Ltd | 103.8 | 3.19% |
| 17 | Aster DM Quality Care Ltd Ordinary Shares | 103.1 | 3.17% |
| 18 | Eris Lifesciences Ltd Registered Shs | 102.8 | 3.16% |
| 19 | Max Healthcare Institute Ltd Ordinary Shares | 99.5 | 3.06% |
| 20 | Dr. Lal PathLabs Ltd | 83.7 | 2.57% |
| 21 | Gland Pharma Ltd | 81.1 | 2.49% |
| 22 | Mankind Pharma Ltd | 68.6 | 2.11% |
| 23 | Narayana Hrudayalaya Ltd | 39.8 | 1.22% |
| 24 | Anthem Biosciences Ltd | 37.6 | 1.16% |
| 25 | Neogen Chemicals Ltd | 20.9 | 0.64% |
| 26 | Biocon Ltd | 16.9 | 0.52% |
| 27 | Torrent Pharmaceuticals Ltd | 14.9 | 0.46% |
| 28 | Deepak Nitrite Ltd | 14.2 | 0.44% |
All disclosed equity positions are shown.